Page last updated: 2024-08-24

plerixafor and Diabetic Cardiomyopathies

plerixafor has been researched along with Diabetic Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byrne, M; Chu, PY; Horlock, D; Jandeleit-Dahm, K; Kaye, DM; Nelson, E; Walder, K; Williams, D; Zimmet, P	1

Other Studies

1 other study(ies) available for plerixafor and Diabetic Cardiomyopathies

Article	Year
CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis. PloS one, 2015, Volume: 10, Issue:7 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzylamines; Biphenyl Compounds; Bone Marrow Transplantation; Chemokine CXCL12; Cyclams; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Ventricles; Hemodynamics; Heterocyclic Compounds; Humans; Mice; Mice, Transgenic; Myofibroblasts; Receptors, CXCR4; Tetrazoles	2015

Article

Year

CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis.

PloS one, 2015, Volume: 10, Issue:7

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzylamines; Biphenyl Compounds; Bone Marrow Transplantation; Chemokine CXCL12; Cyclams; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Ventricles; Hemodynamics; Heterocyclic Compounds; Humans; Mice; Mice, Transgenic; Myofibroblasts; Receptors, CXCR4; Tetrazoles

2015